A Cheat on My Diet Won’t Hurt Me, Right?

Probably not, but the answer actually isn’t that simple. The thing is, some people might feel worse eating a cookie for a cheat meal rather than a slice of pizza. Why do my friends disagree so strongly on the best hangover cures after a night of binge drinking and regretful decisions? There should be some similarity, right? But, it makes sense: every individual is unique, and so is the way they metabolize different foods and drinks.

Sano is a biosensor company that’s looking to give us a little more feedback and understanding from our own bodies. With a simple mobile app that integrates with the sensor, you can check to see real-time data about your body. With this, you can see the immediate metabolic effect of specific foods and drinks or how much fuel you need after exercise. Seems simple enough, but is it a worthwhile idea? Well, let’s take it a little further: who could benefit from a little real-time feedback on metabolic data? Maybe diabetics? Currently, most diabetics take insulin shots solely on a routine and a personal judgment call. Now with Sano, they could find the optimal time for an injection.

This technology isn’t something small, and it’s attracting the attention of the Silicon Valley Venture Capital Community. When it launched, it received a $3.75 Million seed round. In its most recent round of funding, Series A, it raised $15.75 Million lead by Intel Capital and True Ventures. This shows this biosensor has generated a lot of interest and likely to see further product expansion in the market.

While bringing a much needed revolution to the diabetic medical technology, Sano is just the forefront of biosensors and the integration of synthetic biology and biosensors. There are so many potential applications for this technology. For example, if you’re sick right now, you go to the doctor and he prescribes you a pill you take for a few days and eventually you feel better. You might take more than enough, a little less than what you should, but overall it does the job. But what if I paint you a new scenario: you take a nanobot. The nanobot analyzes the virus levels via a biosensors and continuously to dispersing antibiotics so your body contains the optimal amount based of virus levels. This would ensure the optimal treatment method occurs. Right now, that technology isn’t there. But eventually, it will be. In the future, biosensors will be able to screen for diseases, such as metastatic cancer cells spreading, microbial detection, or even food analysis. The possibilities aren’t just limited to the human body: agricultural firms are looking to use it to optimize crop selection for breeding.

Biosensors are going to expand in their applications soon enough. The tools and ideas will not just stay in the lab. Soon real-time measurements from biosensors will be integrated for a lot more technology. Sano taking the first step in measuring glucose for diabetics positions it strongly in the market.